Issues and Solutions in Psychiatric Clinical Trial with Case Studies
DOI: https://doi.org/10.2147/ndt.s454813
IF: 2.989
2024-06-05
Neuropsychiatric Disease and Treatment
Abstract:Xiaochen Chen, 1, &ast Jun Chen, 2, &ast Xue Zhao, 2 Rongji Mu, 1 Hongsheng Tan, 1 Zhangsheng Yu 1, 3 1 Clinical Research Institute & School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China; 2 Clinical Research Center, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China; 3 School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Hongsheng Tan, Clinical Research Institute & School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China, Email Zhangsheng Yu, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 210240, People's Republic of China, Email The coronavirus disease-2019 pandemic resulted in a major increase in depression and anxiety disorders worldwide, which increased the demand for mental health services. However, clinical interventions for treating mental disorders are currently insufficient to meet this growing demand. There is an urgent need to conduct scientific and standardized clinical research that are consistent with the features of mental disorders in order to deliver more effective and safer therapies in the clinic. Our study aimed to expose the challenges, complexities of study design, ethical issues, sample selection, and efficacy evaluation in clinical research for mental disorders. The reliance on subjective symptom presentation and rating scales for diagnosing mental diseases was discovered, emphasizing the lack of clear biological standards, which hampers the construction of rigorous research criteria. We underlined the possibility of psychotherapy in efficacy evaluation alongside medication treatment, proposing for a multidisciplinary approach comprising psychiatrists, neuroscientists, and statisticians. To comprehend mental disorders progression, we recommend the development of artificial intelligence integrated evaluation tools, the use of precise biomarkers, and the strengthening of longitudinal designs. In addition, we advocate for international collaboration to diversity samples and increase the dependability of findings, with the goal of improving clinical research quality in mental disorders through sample representativeness, accurate medical history gathering, and adherence to ethical principles. Keywords: clinical efficacy assessment, clinical trials, mental health, research design, statistical analysis The 2022 World Mental Health Report states that >13% of the world's population have mental disorders. 1 In 2022, the World Health Organization reported that the coronavirus-2019 (COVID-19) outbreak at the end of 2019 significantly increased the incidence of depression and anxiety worldwide by 28% and 26%, respectively. 2 One Chinese study reported that >60% of COVID-19 survivors experienced at least one long-COVID symptom, with depression and anxiety being particularly prominent. 3 Furthermore, in some patients, COVID-19 led to long-term sequelae, such as loss of taste and smell, fatigue, difficulty concentrating, and cognitive decline. 4 Beyond causing persistent negative mental effects and neurological damage, the COVID-19 pandemic has had a profound effect on society as a whole in terms of specific systemic mental syndromes. Currently, diagnosis and treatment of mental disorders are based on scales, questionnaires, and diagnostic classification manuals compiled by Western physicians. These methods lack objective, quantifiable diagnosis, and treatment evaluation indicators. 5 The symptoms and classifications of mental disorders often overlap and are easily influenced by the subjective assessments of psychiatrists, which can lead to misdiagnosis, such as destructive mood disorder being misdiagnosed as bipolar disorder. 6 Medication and psychotherapy are the most frequently used treatments for mental disorders. However, due to the etiological complexity and diversity of mental disorders, identifying precise pharmacological interventions for specific symptoms remains challenging. Existing psychotropic medications often cause adverse reactions. 7 Traditional Chinese medicine and compound prescriptions, such as traditional therapies, have had a long history of use in China. For example, the traditional Chinese medicine formula, namely, Wendan Decoction, was used to treat anxiety and depression in survivors after the 2008 Wenchuan earthquake in China and to alleviate anxiety and insomnia in patients with COVID-19. 8</ -Abstract Truncated-
psychiatry,clinical neurology